GOLPH3 and colorectal carcinoma: Moreover, serum GOLPH3 concentrations in CRC patients at each individual stage (I-IV) were significantly higher than those in healthy controls (all P < 0.001, Figure 3(b)), and there was a significant difference in the median serum GOLPH3 concentrations of GC or CRC patients at different stages (P < 0.001).